ChaseDream
搜索
返回列表 发新帖
00:00:00

The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.

Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the challenge made above?

正确答案: B

更多相关帖子

524

帖子

15

好友

4712

积分

ChaseDream

注册时间
2003-03-17
精华
8
解析
查看: 7681|回复: 9
打印 上一主题 下一主题

请教OG12 CR Q:113, 大家看看我理解的对不对

[复制链接]
跳转到指定楼层
楼主
发表于 2010-5-19 20:51:23 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
113
The pharmaceutical industry argues that because new
drugs will not be developed unless heavy development
costs can be recouped in later sales, the current
20 years of protection provided by patents should
be extended in the case of newly developed drugs.
However, in other industries new-product development
continues despite high development costs, a fact that
indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports
the pharmaceutical industry’s argument against the
challenge made above?

(A) No industries other than the pharmaceutical
industry have asked for an extension of the
20-year limit on patent protection.
(B) Clinical trials of new drugs, which occur after
the patent is granted and before the new drug
can be marketed, often now take as long as
10 years to complete.
(C) There are several industries in which the ratio of
research and development costs to revenues is
higher than it is in the pharmaceutical industry.
(D) An existing patent for a drug does not legally
prevent pharmaceutical companies from
bringing to market alternative drugs, provided
they are sufficiently dissimilar to the patented
drug.
(E) Much recent industrial innovation has occurred
in products—for example, in the computer and
electronics industries—for which patent
protection is often very ineffective.

========================
正确选项是B。B项是不是这样理解:因为Clinical trails 在批准专利到投入市场这段时间是10年,而题目中说的专利保护是20年,所以不需要extension了。
大家是怎么看的呢?
收藏收藏 收藏收藏
沙发
发表于 2010-5-19 21:35:47 | 只看该作者
这个题是说,研发出来的新药要做实验需要10年的时间,而专利保护的时间是20年,所以相当于有10年就浪费掉了,所以研发的费用不recouped,也就是说收不回投资,因此药物公司才想要extend专利保护时间。
板凳
 楼主| 发表于 2010-5-20 10:42:26 | 只看该作者
To wxq,
你这样一解释我一下就明白了,是我弄错了,太谢谢了~
地板
发表于 2010-5-29 15:36:13 | 只看该作者
B 有一点点缺陷是应该加上 ... ; this period for other products is much shorter.

E 也有正确的味道啊. E说most patents of other products 不怎么有效,所以他们不是很care是20年还是30年 (反正没什么用) . 但是对于药品这种产品专利是非常重要的... 有点牵强了 呵呵.
5#
发表于 2010-6-9 15:38:03 | 只看该作者
同意ls的观点,我也是这么认为的应该有两个方向:
方向1:我们研发的时间太长,而其他行业很短,所以应该延长patent的时间收回研发成本,也就是B答案
方向2:我们的行业有有效的专利保护,而其他行业没有,比如computer(顺便联想到我们的山寨阿盗版市场),所以专利的时间效益对其他行业来说是没啥意义的,没必要去延长。。。。。也就是E答案
6#
发表于 2010-8-6 23:35:12 | 只看该作者
http://forum.chasedream.com/GMAT_CR/thread-104734-1-1.html?extparms=ThreadCatalogID%3d0%26page%3d74
7#
发表于 2010-8-7 00:29:20 | 只看该作者
113
The pharmaceutical industry argues that because new
drugs will not be developed unless heavy development
costs can be recouped in later sales, the current
20 years of protection provided by patents should
be extended in the case of newly developed drugs.
However, in other industries new-product development
continues despite high development costs, a fact that
indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports
the pharmaceutical industry’s argument against the
challenge made above?

原文说要有专利需要EX-大概需要20年,而其他行业不需要,问支持。

(A) No industries other than the pharmaceutical
industry have asked for an extension of the
20-year limit on patent protection.

other than the pharmaceutical-范围不对,杀

(B) Clinical trials of new drugs, which occur after
the patent is granted and before the new drug
can be marketed, often now take as long as
10 years to complete.

临床试验需要时间什么的,沾,先放着

(C) There are several industries in which the ratio of
research and development costs to revenues is
higher than it is in the pharmaceutical industry.

ratio不可得知,杀

(D) An existing patent for a drug does not legally
prevent pharmaceutical companies from
bringing to market alternative drugs, provided
they are sufficiently dissimilar to the patented
drug.

does not legally  prevent 驳斥原文,杀

(E) Much recent industrial innovation has occurred
in products—for example, in the computer and
electronics industries—for which patent
protection is often very ineffective.

ineffective——原文没讨论这个东西,原文讨论的是EX-需不需要而不是专利保护有没有效,ISSUE不同,杀。

选B
8#
发表于 2013-10-31 12:13:03 | 只看该作者
treepple 发表于 2010-6-9 15:38
同意ls的观点,我也是这么认为的应该有两个方向:方向1:我们研发的时间太长,而其他行业很短,所以应该延 ...

所以E是weaken了医药工业的argument啊!但是题目问的是support
9#
发表于 2015-12-2 10:17:49 | 只看该作者
我也被这道题难倒了!这是我的笔记,希望对cder有帮助!!up up
10#
发表于 2015-12-2 10:21:06 | 只看该作者
(A)  No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.(无关选项/或方向相反。其他工厂的情况可能跟制药厂不同。即使这句话成立,也是weaken了制药厂的argument)
(B)  Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.(新信息。新药品的临床试验就花了10年,原来专利年限是20年,这样也就是浪费了10年的专利,这10年是没有回报的,所以可能需要延长专利来收回成本)
(C)  There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.(跟专利扯不上关系呀!!即使有关,说成本利润比值高,只能说明成本高,然后呢。。然后呢。。然后就没有然后了。。。所以不能选呀!!)
(D)  An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.(方向相反。既然既有的专利都不能保护了,延长年限也保护不了呀!所以不需要延长年限,所以支持了第二个观点,但题干要我们选支持第一个观点的)
(E)  Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.(无关/方向相反。不同工厂能比吗?即使能比,都说专题保护无效了,延长了也无效,所以不需要。同D)
01. 首先要读懂题目问的是什么!!!题目的意思是问哪个选项支持制药厂的观点,而不是削弱呀!!!
supports the pharmaceutical industry’s argument才是重点呀!!!against the challenge 是修饰argument的!!!这里的challenge是第二个观点,也就是说不需要延长专利年限的那个观点。第二个观点是第一个观点的challenge, 第一个观点与第二个观点对立,所以是against the challenge ,反对第二个观点!!!
02. 所以这道题所要支持的是pharmaceutical industry’s argument,第一句话的观点!!也就是支持需要延长制药厂新药品的专利年限。
03.渣渣的我发现搞清方向特别重要
您需要登录后才可以回帖 登录 | 立即注册

Mark一下! 看一下! 顶楼主! 感谢分享! 快速回复:

手机版|ChaseDream|GMT+8, 2024-11-13 07:27
京公网安备11010202008513号 京ICP证101109号 京ICP备12012021号

ChaseDream 论坛

© 2003-2023 ChaseDream.com. All Rights Reserved.

返回顶部